Enhanced Ca2+ influx from STIM1–Orai1 induces muscle pathology in mouse models of muscular dystrophy
Open Access
- 20 February 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 23 (14) , 3706-3715
Abstract
Muscular dystrophy is a progressive muscle wasting disease that is thought to be initiated by unregulated Ca2+ influx into myofibers leading to their death. Store-operated Ca2+ entry (SOCE) through sarcolemmal Ca2+ selective Orai1 channels in complex with STIM1 in the sarcoplasmic reticulum is one such potential disease mechanism for pathologic Ca2+ entry. Here, we generated a mouse model of STIM1 overexpression in skeletal muscle to determine whether this type of Ca2+ entry could induce muscular dystrophy. Myofibers from muscle-specific STIM1 transgenic mice showed a significant increase in SOCE in skeletal muscle, modeling an observed increase in the same current in dystrophic myofibers. Histological and biochemical analysis of STIM1 transgenic mice showed fulminant muscle disease characterized by myofiber necrosis, swollen mitochondria, infiltration of inflammatory cells, enhanced interstitial fibrosis and elevated serum creatine kinase levels. This dystrophic-like disease in STIM1 transgenic mice was abrogated by crossing in a transgene expressing a dominant-negative Orai1 (dnOrai1) mutant. The dnOrai1 transgene also significantly reduced the severity of muscular dystrophy in both mdx (dystrophin mutant mice) and δ-sarcoglycan-deficient (Sgcd−/−) mouse models of disease. Hence, Ca2+ influx across an unstable sarcolemma due to increased activity of a STIM1–Orai1 complex is a disease determinant in muscular dystrophy, and hence, SOCE represents a potential therapeutic target.Keywords
This publication has 52 references indexed in Scilit:
- STIM1L is a new actin-binding splice variant involved in fast repetitive Ca2+ releaseJournal of Cell Biology, 2011
- Stoichiometric requirements for trapping and gating of Ca 2+ release-activated Ca 2+ (CRAC) channels by stromal interaction molecule 1 (STIM1)Proceedings of the National Academy of Sciences, 2011
- Debio-025 is more effective than prednisone in reducing muscular pathology in mdx miceNeuromuscular Disorders, 2010
- Calcium influx is sufficient to induce muscular dystrophy through a TRPC-dependent mechanismProceedings of the National Academy of Sciences, 2009
- Native Store-operated Ca2+ Influx Requires the Channel Function of Orai1 and TRPC1Journal of Biological Chemistry, 2009
- STIM1 signalling controls store-operated calcium entry required for development and contractile function in skeletal muscleNature Cell Biology, 2008
- Functional Requirement for Orai1 in Store-operated TRPC1-STIM1 ChannelsJournal of Biological Chemistry, 2008
- Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophyNature Medicine, 2008
- Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release–activated calcium channelsNature Immunology, 2007
- Molecular basis of the CRAC channelCell Calcium, 2007